Loading…
← CockpitCompetitor Analysis › 1789.HK AK Medical Holdings Ltd.Open in the cockpit ↗

AK Medical Holdings Ltd.1789.HKCompetitor analysis, valuation and peers

Hong Kong · HKD·Health Care›Medical Specialties
Momentum neutral 45
Mkt cap
$642M
US dollars, full cap
Free float
48%
of shares outstanding
$/day
$1.74M
20-day average traded
Fwd P/E
10.5×
forward earnings
ROIC−WACC
+14.3 pp
WACC 6.5%
Hurdle
-18 pp
Req g minus delivered
Next earnings
133 days
31 Mar 2027
Close · HKDHK$4.65
1D-0.6%
1W-2.4%
1M+3.6%
3M-19.8%
6M-23.1%
YTD-18.4%
1Y-21.3%
ATR %3.4%
52w lowhigh35.0% off high

What AK Medical does

Employees: 983

AK Medical at a glance

Size AK Medical (1789.HK) is a Hong Kong Health Care company (Medical Specialties) with a market value of $642M, the 685th largest of 885 Hong Kong companies the cockpit tracks. Shares closed at HK$4.65 on 18 Nov 2026.

Performance Over six months the shares fell 23.1%, against -6.6% for the median peer and -14.0% for the Hong Kong market (cap-weighted) — 4th lowest of 19 in its peer set.

Growth Revenue grew 16.1% over the last twelve months (peer median +16.2%); the operating margin is 26.4% (peer median 9.5%).

Valuation It trades at 10.5× forward earnings against a peer median of 27.9× (2nd cheapest of 15).

Price implies For today's price to make sense, revenue must grow about -12% a year for seven years (Req g). Recent delivered growth is +7%, so the hurdle is -18 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 14.3 points above its cost of capital (6.5% WACC).

Next results Next results expected around 31 Mar 2027 (exchange calendar; dates can move).

Relative performance

70809010021 May 202621 Aug 202618 Nov 2026Peer median 941789.HK 77
Six months, rebased to 100: AK Medical against the median of its 20 peers (local-currency closes).

AK Medical financials

Reported figures in HKD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueHK$1.73BHK$1.61BHK$1.46BHK$1.21BHK$1.22B
Revenue growth—+10%+21%-1%—
Gross profitHK$1.09BHK$948MHK$854MHK$729MHK$726M
EBITDAHK$582MHK$489MHK$413MHK$305MHK$358M
Net incomeHK$420MHK$368MHK$297MHK$201MHK$238M
Free cash flowHK$369MHK$352MHK$341M-HK$140MHK$170M
Capital expenditureHK$89.4MHK$134MHK$176MHK$217MHK$138M
Total debtn/aHK$161MHK$138MHK$119MHK$43.5M

Quarterly statements and history in the cockpit →

AK Medical competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%+100%+150%-20%0%+20%18584728QDELSNT300326XVIVO002876DCTH491000MEDISGHTTCMD3012343003141789.HK6-month return →1-month return →
Up and to the right = strong over both horizons. AK Medical is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%0×200×1858QDELSNT300326XVIVO002876DCTHNANMEDI6883896885813003141789.HKRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. AK Medical is the large dot.

Capital: growth delivered against growth the price implies

0%+50%+100%0%50%100%18584728SNT300326XVIVO002876DCTHNANMEDI6880853012346885811789.HKGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. AK Medical is the large dot.

AK Medical competitors and peer comparison

How AK Medical compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

AK Medical against its 20 peers (data as of 18 Nov 2026)
Measure1789.HKPeer medianRank in peer set
1-month return+3.6%-2.5%6th highest of 19
6-month return-23.1%-6.6%4th lowest of 19
Distance from 52-week high-35.0%-26.0%7th lowest of 20
Revenue growth (TTM)+16.1%+16.2%10th lowest of 20
Operating margin26.4%9.5%5th highest of 20
Forward P/E10.5×27.9×2nd cheapest of 15
Growth the price implies (Req g, 7 yrs)-11.5%9.3%least demanding of 15
Growth delivered (Del g)+6.7%+13.7%4th lowest of 15
Hurdle (Req g minus delivered)-18.2 pp-3.8 pp5th least demanding of 15
ROIC minus cost of capital+14.3 pp+2.5 pp5th highest of 20
EV / EBITDA6.3×18.6×cheapest of 9
Net debt / EBITDA-2.3×-0.8×3rd least indebted of 9

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
AK Medical 1789.HKHong Kong$642M-23%+16%26%10.5×-11.5%+6.7%
Beijing Chunlizhengda Medical Instruments 1858.HKHong Kong$631M-28%-9%31%8.5×-9.5%+1.5%
SunMax Biotechnology 4728.TWOTaiwan$630M0%+19%51%n/a-2.6%+18.8%
QuidelOrtho QDELUnited States$657M-20%-5%-2%10.7×n/an/a
Synektik SNT.WAPoland$662M+10%+32%24%13.8×0.2%+47.5%
Shanghai Kinetic Medical 300326.SZChina$662M-10%-28%17%26.0×6.6%-1.9%
Xvivo Perfusion XVIVO.STSweden$611M-32%+18%12%53.1×35.9%+35.2%
Shenzhen Sunnypol Optoelectornics 002876.SZChina$680M-9%+29%5%39.0×10.1%+14.2%
Delcath Systems DCTHUnited States$685M+75%+38%5%358.9×33.4%+120.2%
Livsmed 491000.KSSouth Korea$687M-47%+89%-77%n/an/an/a
Nanosonics NAN.AXAustralia$599M-4%+3%7%98.6×35.3%+6.7%
Medistim MEDI.OLNorway$599M+32%+19%29%31.8×-1.2%+14.5%
Sight Sciences SGHTUnited States$599M+122%+16%-30%n/an/an/a
Shenzhen Lifotronic Technology 688389.SSChina$692M-14%+14%13%29.9×11.6%+13.3%
Sahajanand Medical Technologies SMT.NSIndia$595Mn/an/an/an/an/an/a
Shanghai Sanyou Medical 688085.SSChina$692M-23%+15%4%50.0×29.0%+6.8%
vVARDIS VVVVUnited States$594Mn/a+148%-72%n/an/an/a
Tactile Systems Technology TCMDUnited States$592M+6%+14%9%21.1×8.4%+12.0%
Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZChina$697M+148%-14%3%n/a31.8%-0.6%
Hangzhou AGS MedTech 688581.SSChina$590M-22%-18%33%18.9×0.4%+27.8%
Ningbo David Medical Device 300314.SZChina$589M+25%+19%11%12.0×n/an/a

Questions

Which companies are AK Medical's closest peers?
The cockpit's peer set: Beijing Chunlizhengda Medical Instruments (1858.HK), SunMax Biotechnology (4728.TWO), QuidelOrtho (QDEL), Synektik (SNT.WA), Shanghai Kinetic Medical (300326.SZ), Xvivo Perfusion (XVIVO.ST), Shenzhen Sunnypol Optoelectornics (002876.SZ), Delcath Systems (DCTH).
Is AK Medical expensive compared with its peers?
On forward p/e it trades at 10.5× against a peer median of 27.9×, 2nd cheapest of 15 in its peer set. For today's price to make sense, revenue must grow about -12% a year for seven years (Req g). Recent delivered growth is +7%, so the hurdle is -18 pp: the price already allows for a slowdown.
How has AK Medical stock performed?
Over six months to 18 Nov 2026 the shares returned -23.1% against -6.6% for the median peer; over one year -21.3%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.